Merck KGaA of Germany officially opened its new $189 million China pharmaceutical plant in Nantong and announced another $89 million investment in a nearby Life Science center. The Nantong facility will produce drugs for China’s Essential Drug List while the new Life Science Center will manufacture high-purity inorganic salts, cell culture media products as well as ready-to-use media for drug discovery and production. Merck said the plants will help transform Merck from an importing company to a local China pharma.
